| Literature DB >> 22776703 |
Anthony J Maher1, Timothy E Kilmartin.
Abstract
BACKGROUND: In the United Kingdom patient-reported outcome measures (PROMS) have been adopted as a key measure of foot surgery outcomes. The intention of this study was to evaluate the responsiveness of a regional outcome measure; the Manchester Oxford Foot Questionnaire (MOXFQ) and a generic measure; the EuroQol EQ-5D, in the context of day care Podiatric Surgery.Entities:
Year: 2012 PMID: 22776703 PMCID: PMC3489846 DOI: 10.1186/1757-1146-5-17
Source DB: PubMed Journal: J Foot Ankle Res ISSN: 1757-1146 Impact factor: 2.303
Study period, Recruitment and Patient Demographics
| 375 | Lost to follow up | 60 | |
|---|---|---|---|
| Patients Included in study | 315 | | |
| Patients with surgical data | 315 | | |
| Patients with pre/post MOXFQ | 304 | | |
| Patients with pre/post EQ-5D | 279 | | |
| | | | |
| Start | 18/05/2009 | Finish | 26/10/2010 |
| Mean follow up (wks) | 26.9 | (SD 4.3) | |
| Min follow up | 17 | Max followup | 79 |
| | | | |
| Min | 17 | Max | 88 |
| Mean | 58.5 | (SD12.3) | |
| Female | 85% | Male | 15% |
| | | | |
| 1 | 43.8% | | |
| 2 | 53.3% | | |
| 3 | 2.9% |
Summary of Surgical Intervention
| Pt's receiving more than one procedure | 81 |
| Mean procedures per patient | 1.298 |
| | |
| Hallx valgus repair (scarf-Akins procedure) | 156 |
| Digital surgery | 132 |
| Hallux Rigidus repair (osteotomy, arthroplasty, arthrodesis) | 29 |
| Skin, nail or Soft tissue | 22 |
| Lesser metatarsal (osteotomy, condylectomy) | 19 |
| Neurectomy | 19 |
| Cheilectomy | 13 |
| mid foot arthrodesis | 5 |
| Fixation removal | 5 |
| amputation (Digital; whole or partial) | 3 |
| sesamoid reduction | 3 |
| Hallux Varus repair (Reverse scarf procedure) | 2 |
| Sub Talar joint Arthroeresis | 1 |
Surgical Complications recorded post operation
| Incision line healing | 16 | 5.08 |
| Recurrence | 16 | 5.08 |
| Transfer metatarsalgia | 10 | 3.17 |
| Infection suspected | 7 | 2.22 |
| Pain around site of surgery | 7 | 2.22 |
| Other | 6 | 1.90 |
| Swelling (abnormal) | 5 | 1.59 |
| Joint pain and stiffness | 5 | 1.59 |
| Scar line | 4 | 1.27 |
| Medication side effect | 4 | 1.27 |
| Infection proven | 2 | 0.63 |
| DVT (confirmed) | 2 | 0.63 |
| Sensory loss (small) | 2 | 0.63 |
| D.V.T (suspected) | 1 | 0.32 |
| 87 |
Summary of mean MOXFQ domain scores and mean EQ-5D scores pre and post treatment
| Walking | 50.2 | 26.0 | 14.1 | 20.5 | 36.1 | 27.9 | <0.0001 | 1.39 | |
| | Pain | 51.7 | 23.1 | 16.5 | 19.0 | 35.2 | 25.9 | <0.0001 | 1.52 |
| | Social | 45.7 | 25.3 | 10.6 | 17.4 | 35.1 | 27.3 | <0.0001 | 1.39 |
| Index | 0.7 | 0.2 | 0.9 | 0.2 | 0.2 | 0.1 | <0.0001 | 0.83 | |
| VAS | 8.1 | 1.6 | 8.2 | 1.7 | 0.1 | 3.2 | 0.3050 | 0.04 | |
*Sig; significance. *ES; Effect Size. SD; Standard deviation.
Analysis of EQ-5D and MOXFQ minimal clinically important differences following treatment
| | ||||||||
|---|---|---|---|---|---|---|---|---|
| 5.0 | 1.8 | 18.0 | 5.9 | 18.0 | 5.9 | 23.0 | 7.5 | |
| 53.0 | 19.0 | 35.0 | 11.5 | 59.0 | 19.3 | 73.0 | 23.9 | |
| 221.0 | 79.2 | 252.0 | 82.6 | 228.0 | 74.8 | 209.0 | 68.5 | |
| 279.0 | 100.0 | 305.0 | 100.0 | 305.0 | 100.0 | 305.0 | 100.0 | |
EQ-5D items
| Pre | 156 | 11 | 136 | 249 | 70 |
| Post | 67 | 11 | 47 | 104 | 38 |
| Effect Size | 0.63 | 0.00 | 0.61 | 1.25 | 0.24 |
The table lists the number of Patients reporting problems for each EQ-5D item pre and post surgery (with effect size).